Mechanism of Action: Cytochrome P450 2C19 Inducers
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 2C19 Inducers
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | CARBAMAZEPINE | carbamazepine | SUSPENSION;ORAL | 214277-001 | Oct 6, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | CARBAMAZEPINE | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 201106-003 | Jun 21, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Torrent Pharms | CARBAMAZEPINE | carbamazepine | TABLET;ORAL | 077272-004 | Dec 7, 2005 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Nostrum Labs Inc | CARBAMAZEPINE | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 076697-003 | May 20, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Unique Pharm | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 211623-003 | Apr 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | CARBAMAZEPINE | carbamazepine | SUSPENSION;ORAL | 075714-001 | Jun 5, 2002 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Epic Pharma Llc | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216235-001 | Mar 2, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
